Journal article
Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p
- Abstract:
-
Genome-wide association studies have identified a region on chromosome 9p that is associated with coronary artery disease (CAD). The region is also associated with type 2 diabetes (T2D), a risk factor for CAD, although different SNPs were reported to be associated to each disease in separate studies. We have undertaken a case-control study in 4251 CAD cases and 4443 controls in four European populations using previously reported ('literature') and tagging SNPs. We replicated the literature SN...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Version of record, pdf, 106.8KB)
-
(Version of record, xls, 29.0KB)
-
(Version of record, xls, 20.5KB)
-
(Version of record, pdf, 215.1KB)
-
- Publisher copy:
- 10.1093/hmg/ddm352
Funding
Bibliographic Details
- Publisher:
- Oxford University Press Publisher's website
- Journal:
- Human Molecular Genetics Journal website
- Volume:
- 17
- Issue:
- 6
- Pages:
- 806-814
- Publication date:
- 2008-03-01
- DOI:
- EISSN:
-
1460-2083
- ISSN:
-
0964-6906
Item Description
- Language:
- English
- Keywords:
- Subjects:
- UUID:
-
uuid:a8482ded-08fc-4bb5-aa3d-248eb81566bd
- Local pid:
- ora:2403
- Deposit date:
- 2008-10-29
Related Items
Terms of use
- Copyright holder:
- H M Broadbent et al
- Copyright date:
- 2007
- Notes:
- Citation: Broadbent, H. M. et al. (2008). 'Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p', Human Molecular Genetics, 17(6), 806-814. [Available at http://hmg.oxfordjournals.org/]. Copyright 2007 the authors. This is an Open Access article distributed under the terms of the Creative Common Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. N.B. This article was also funded by AstraZeneca.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record